HEV-associated neuralgic amyotrophy: a multicentric case series

Background: Neuralgic amyotrophy (NA) has been described as a possible extrahepatic manifestation of hepatitis E virus (HEV) infection. Usually, HEV-associated NA occurs bilaterally. The clinical characteristics determining the course of HEV-associated NA have still not been defined. Methods: In thi...

Full description

Saved in:
Bibliographic Details
Main Authors: Bannasch, Johannes H. (Author) , Berger, Benjamin (Author) , Schwartkop, Claus-Peter (Author) , Berning, Marco (Author) , Goetze, Oliver (Author) , Panning, Marcus (Author) , Fritz-Weltin, Miriam (Author) , Trendelenburg, George (Author) , Gelderblom, Mathias (Author) , Lütgehetmann, Marc (Author) , Stute, Fridrike (Author) , Horvatits, Thomas (Author) , Dirks, Meike (Author) , Antoni, Christoph Helmer (Author) , Behrendt, Patrick (Author) , Pischke, Sven (Author)
Format: Article (Journal)
Language:English
Published: 30 May 2021
In: Pathogens
Year: 2021, Volume: 10, Issue: 6, Pages: 1-11
ISSN:2076-0817
DOI:10.3390/pathogens10060672
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/pathogens10060672
Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/2076-0817/10/6/672
Get full text
Author Notes:Johannes H. Bannasch, Benjamin Berger, Claus-Peter Schwartkop, Marco Berning, Oliver Goetze, Marcus Panning, Miriam Fritz-Weltin, George Trendelenburg, Mathias Gelderblom, Marc Lütgehetmann, Fridrike Stute, Thomas Horvatits, Meike Dirks, Christoph Antoni, Patrick Behrendt and Sven Pischke

MARC

LEADER 00000caa a2200000 c 4500
001 176766091X
003 DE-627
005 20241231020450.0
007 cr uuu---uuuuu
008 210823s2021 xx |||||o 00| ||eng c
024 7 |a 10.3390/pathogens10060672  |2 doi 
035 |a (DE-627)176766091X 
035 |a (DE-599)KXP176766091X 
035 |a (OCoLC)1341420894 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Bannasch, Johannes H.  |e VerfasserIn  |0 (DE-588)1239590849  |0 (DE-627)1767660642  |4 aut 
245 1 0 |a HEV-associated neuralgic amyotrophy  |b a multicentric case series  |c Johannes H. Bannasch, Benjamin Berger, Claus-Peter Schwartkop, Marco Berning, Oliver Goetze, Marcus Panning, Miriam Fritz-Weltin, George Trendelenburg, Mathias Gelderblom, Marc Lütgehetmann, Fridrike Stute, Thomas Horvatits, Meike Dirks, Christoph Antoni, Patrick Behrendt and Sven Pischke 
264 1 |c 30 May 2021 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 23.08.2021 
520 |a Background: Neuralgic amyotrophy (NA) has been described as a possible extrahepatic manifestation of hepatitis E virus (HEV) infection. Usually, HEV-associated NA occurs bilaterally. The clinical characteristics determining the course of HEV-associated NA have still not been defined. Methods: In this retrospective multicentric case series, 16 patients with HEV-associated NA were studied and compared to 176 HEV patients without NA in terms of their age, sex, and ALT levels. Results: Neither gender distribution (75% vs. 67% male) nor age (47 vs. 48 years median) differed significantly between the NA patients and controls. Eight NA patients (50%) presented with bilateral involvement—seven of these had right-side dominance and one had left-side dominance. Thirteen cases (81%) were hospitalized. Eight of these patients stayed in hospital for five to seven days, and five patients stayed for up to two weeks. The time from the onset of NA to the HEV diagnosis, as well as the diagnostic and therapeutic proceedings, showed a large variability. In total, 13 (81%) patients received treatment: 1/13 (8%) received intravenous immunoglobulins, 8/13 (62%) received glucocorticoids, 3/13 (23%) received ribavirin, and 6/13 (46%) received pregabalin/gabapentin. Patients with ages above the median (47 years) were more likely to be treated (p = 0.001). Conclusion: HEV-associated NA causes a relevant morbidity. In our case series neither the type of treatment nor the time of initiation of therapy had a significant effect on the duration of hospitalization or the course of the disease. The clinical presentation, the common diagnostic and therapeutic procedures, and the patients’ characteristics showed large variability, demonstrating the necessity of standardized protocols for this rare but relevant disease. 
650 4 |a Hepatitis E 
650 4 |a HEV 
650 4 |a NA 
650 4 |a neuralgic amyotrophy 
700 1 |8 1\p  |a Berger, Benjamin  |d 1978-  |e VerfasserIn  |0 (DE-588)132531526  |0 (DE-627)523627114  |0 (DE-576)260041343  |4 aut 
700 1 |a Schwartkop, Claus-Peter  |e VerfasserIn  |4 aut 
700 1 |8 2\p  |a Berning, Marco  |d 1978-  |e VerfasserIn  |0 (DE-588)13058956X  |0 (DE-627)504167553  |0 (DE-576)241644208  |4 aut 
700 1 |a Goetze, Oliver  |e VerfasserIn  |4 aut 
700 1 |8 3\p  |a Panning, Marcus  |d 1971-  |e VerfasserIn  |0 (DE-588)128590556  |0 (DE-627)376260904  |0 (DE-576)29723062X  |4 aut 
700 1 |8 4\p  |a Fritz-Weltin, Miriam  |d 1984-  |e VerfasserIn  |0 (DE-588)14291617X  |0 (DE-627)640916422  |0 (DE-576)334025672  |4 aut 
700 1 |8 5\p  |a Trendelenburg, George  |d 1966-  |e VerfasserIn  |0 (DE-588)120392127  |0 (DE-627)080645887  |0 (DE-576)179287281  |4 aut 
700 1 |8 6\p  |a Gelderblom, Mathias  |d 1974-  |e VerfasserIn  |0 (DE-588)130454176  |0 (DE-627)50184614X  |0 (DE-576)298205378  |4 aut 
700 1 |8 7\p  |a Lütgehetmann, Marc  |d 1975-  |e VerfasserIn  |0 (DE-588)13152478X  |0 (DE-627)510499295  |0 (DE-576)298562936  |4 aut 
700 1 |a Stute, Fridrike  |d 1977-  |e VerfasserIn  |0 (DE-588)132301725  |0 (DE-627)521409810  |0 (DE-576)299061191  |4 aut 
700 1 |8 8\p  |a Horvatits, Thomas  |d 1985-  |e VerfasserIn  |0 (DE-588)1252980264  |0 (DE-627)1794838406  |4 aut 
700 1 |8 9\p  |a Dirks, Meike  |d 1982-  |e VerfasserIn  |0 (DE-588)142808318  |0 (DE-627)64013291X  |0 (DE-576)333508661  |4 aut 
700 1 |a Antoni, Christoph Helmer  |d 1968-  |e VerfasserIn  |0 (DE-588)120403269  |0 (DE-627)696641100  |0 (DE-576)292200846  |4 aut 
700 1 |a Behrendt, Patrick  |e VerfasserIn  |4 aut 
700 1 |a Pischke, Sven  |d 1976-  |e VerfasserIn  |0 (DE-588)131625306  |0 (DE-627)511709501  |0 (DE-576)298633515  |4 aut 
773 0 8 |i Enthalten in  |t Pathogens  |d Basel : MDPI, 2012  |g 10(2021), 6, Artikel-ID 672, Seite 1-11  |h Online-Ressource  |w (DE-627)732627885  |w (DE-600)2695572-6  |w (DE-576)377126462  |x 2076-0817  |7 nnas  |a HEV-associated neuralgic amyotrophy a multicentric case series 
773 1 8 |g volume:10  |g year:2021  |g number:6  |g elocationid:672  |g pages:1-11  |g extent:11  |a HEV-associated neuralgic amyotrophy a multicentric case series 
856 4 0 |u https://doi.org/10.3390/pathogens10060672  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.mdpi.com/2076-0817/10/6/672  |x Verlag  |z lizenzpflichtig  |3 Volltext 
883 |8 1\p  |a cgwrk  |d 20241001  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
883 |8 2\p  |a cgwrk  |d 20241001  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
883 |8 3\p  |a cgwrk  |d 20241001  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
883 |8 4\p  |a cgwrk  |d 20241001  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
883 |8 5\p  |a cgwrk  |d 20241001  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
883 |8 6\p  |a cgwrk  |d 20241001  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
883 |8 7\p  |a cgwrk  |d 20241001  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
883 |8 8\p  |a cgwrk  |d 20241001  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
883 |8 9\p  |a cgwrk  |d 20241001  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
951 |a AR 
992 |a 20210823 
993 |a Article 
994 |a 2021 
998 |g 120403269  |a Antoni, Christoph Helmer  |m 120403269:Antoni, Christoph Helmer  |d 60000  |d 61100  |e 60000PA120403269  |e 61100PA120403269  |k 0/60000/  |k 1/60000/61100/  |p 14 
999 |a KXP-PPN176766091X  |e 3970729653 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedDisp":"30 May 2021","dateIssuedKey":"2021"}],"note":["Gesehen am 23.08.2021"],"title":[{"subtitle":"a multicentric case series","title_sort":"HEV-associated neuralgic amyotrophy","title":"HEV-associated neuralgic amyotrophy"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"person":[{"display":"Bannasch, Johannes H.","family":"Bannasch","given":"Johannes H.","role":"aut"},{"family":"Berger","display":"Berger, Benjamin","given":"Benjamin","role":"aut"},{"given":"Claus-Peter","role":"aut","family":"Schwartkop","display":"Schwartkop, Claus-Peter"},{"display":"Berning, Marco","family":"Berning","role":"aut","given":"Marco"},{"display":"Goetze, Oliver","family":"Goetze","role":"aut","given":"Oliver"},{"given":"Marcus","role":"aut","display":"Panning, Marcus","family":"Panning"},{"given":"Miriam","role":"aut","family":"Fritz-Weltin","display":"Fritz-Weltin, Miriam"},{"given":"George","role":"aut","family":"Trendelenburg","display":"Trendelenburg, George"},{"given":"Mathias","role":"aut","family":"Gelderblom","display":"Gelderblom, Mathias"},{"role":"aut","given":"Marc","display":"Lütgehetmann, Marc","family":"Lütgehetmann"},{"display":"Stute, Fridrike","family":"Stute","role":"aut","given":"Fridrike"},{"family":"Horvatits","display":"Horvatits, Thomas","given":"Thomas","role":"aut"},{"role":"aut","given":"Meike","display":"Dirks, Meike","family":"Dirks"},{"role":"aut","given":"Christoph Helmer","family":"Antoni","display":"Antoni, Christoph Helmer"},{"display":"Behrendt, Patrick","family":"Behrendt","given":"Patrick","role":"aut"},{"family":"Pischke","display":"Pischke, Sven","given":"Sven","role":"aut"}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"recId":"732627885","pubHistory":["1.2012 -"],"id":{"zdb":["2695572-6"],"eki":["732627885"],"issn":["2076-0817"]},"disp":"HEV-associated neuralgic amyotrophy a multicentric case seriesPathogens","part":{"issue":"6","extent":"11","volume":"10","year":"2021","text":"10(2021), 6, Artikel-ID 672, Seite 1-11","pages":"1-11"},"note":["Gesehen am 14.12.12"],"origin":[{"dateIssuedKey":"2012","publisher":"MDPI","dateIssuedDisp":"2012-","publisherPlace":"Basel"}],"title":[{"title_sort":"Pathogens","title":"Pathogens"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"]}],"id":{"eki":["176766091X"],"doi":["10.3390/pathogens10060672"]},"name":{"displayForm":["Johannes H. Bannasch, Benjamin Berger, Claus-Peter Schwartkop, Marco Berning, Oliver Goetze, Marcus Panning, Miriam Fritz-Weltin, George Trendelenburg, Mathias Gelderblom, Marc Lütgehetmann, Fridrike Stute, Thomas Horvatits, Meike Dirks, Christoph Antoni, Patrick Behrendt and Sven Pischke"]},"physDesc":[{"extent":"11 S."}],"recId":"176766091X"} 
SRT |a BANNASCHJOHEVASSOCIA3020